Form 8-K · Current report

Wabtec 8-K, filed Nov 3, 2026

Filed
CIK
0000943452
Accession no.
0001140361-26-041841
AI-generated summary

Summary

Wabtec priced a $500 million public offering of 5.900% senior notes due 2037, to be guaranteed by its current and future subsidiaries that guarantee its other indebtedness. The company intends to use the net proceeds, along with borrowings under its credit facilities and commercial paper program, to repay its 3.450% senior notes maturing November 15, 2026.

Key points

  • The notes mature February 25, 2037 and pay interest semi-annually in arrears.
  • The sale is expected to close November 4, 2026, subject to customary closing conditions.
  • BofA Securities, Citigroup Global Markets, PNC Capital Markets and TD Securities (USA) are joint book-running managers.
  • The offering is being made under an automatic shelf registration statement on Form S-3.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 8.01Other Events
  • 9.01Financial Statements and Exhibits

From the filing

Item 8.01. Other Events. In connection with its public offering (the “Offering”) of $500 million aggregate principal amount of its 5.900% Senior Notes due 2037 (the “Notes”), Westinghouse Air Brake Technologies Corporation (the “Company”) is filing herewith as Exhibit 1.1 the Underwriting Agreement, dated November 2, 2026 (the “Underwriting Agreement”), by and among the Company, the subsidiary guarantors party thereto and BofA Securities, Inc., Citigroup Global Markets Inc., PNC Capital Markets LLC and TD Securities (USA) LLC. The Offering is being conducted pursuant to the Company’s shelf registration statement on Form S-3 (File No. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Wabtec in Readster

Add Wabtec to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.